New potential treatment for age-related macular degeneration offers hope to patients as phase III trials begin in Bristol, UK
Patients in Bristol suffering from geographic atrophy can now enroll in the phase III clinical program for lampalizumab, a drug being investigated for this form of age-related macular degeneration...